Sera Prognostics, Inc. (NASDAQ:SERA) Insider Robert Gardner Harrison Sells 2,264 Shares

Sera Prognostics, Inc. (NASDAQ:SERA) insider Robert Gardner Harrison sold 2,264 shares of the company’s stock in a transaction on Monday, January 13th. The stock was sold at an average price of $6.47, for a total transaction of $14,648.08. Following the completion of the transaction, the insider now directly owns 114,573 shares in the company, valued at approximately $741,287.31. The trade was a 1.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Robert Gardner Harrison also recently made the following trade(s):

• On Friday, January 10th, Robert Gardner Harrison sold 14,209 shares of Sera Prognostics stock. The shares were sold at an average price of $7.39, for a total value of $105,004.51.

Sera Prognostics Price Performance

Shares of NASDAQ SERA opened at $6.60 on Friday. The business has a 50-day moving average of $7.40 and a 200-day moving average of $7.31. Sera Prognostics, Inc. has a 12 month low of $4.98 and a 12 month high of $12.35.

Sera Prognostics (NASDAQ:SERA) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.02). The business had revenue of $0.03 million for the quarter, compared to analyst estimates of $0.09 million. During the same period in the previous year, the company posted ($0.23) earnings per share. Analysts predict that Sera Prognostics, Inc. will post -0.96 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in SERA. Bank of New York Mellon Corp lifted its stake in Sera Prognostics by 100.2% during the second quarter. Bank of New York Mellon Corp now owns 150,708 shares of the company’s stock worth $892,000 after purchasing an additional 75,441 shares during the last quarter. Rhumbline Advisers bought a new stake in Sera Prognostics in the 2nd quarter worth approximately $190,000. American Century Companies Inc. boosted its stake in Sera Prognostics by 12.7% in the second quarter. American Century Companies Inc. now owns 25,682 shares of the company’s stock worth $152,000 after buying an additional 2,891 shares in the last quarter. Renaissance Technologies LLC bought a new position in Sera Prognostics during the second quarter valued at approximately $162,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Sera Prognostics during the second quarter worth approximately $68,000. Institutional investors own 54.64% of the company’s stock.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.